
|Videos|September 16, 2021
Dr. Elterman weighs in on the growing number of BPH treatments available
Author(s)Urology Times staff
“My patient selection process for BPH treatments can be a little bit cumbersome and take time, but that's really because for the first time ever, we have so many different options available to men,” says Dean Elterman, MD, MSc, FRCSC.
Advertisement
In this video, Dean Elterman, MD, MSc, FRCSC, discusses the patient selection process and methods he uses to conduct BPH treatment studies, specifically implementing Rezum and Aquablation therapies. Elterman is an associate professor of urology at University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










